Skip to main content
ALLO logo

Allogene Therapeutics, Inc.

ALLONASDAQHealthcareBiotechnology

$1.31Today:- (-)1Y +8.94%

As of Oct 16, 2026 close

Market cap
$440.77M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.04$4.46
Volume (live)
-
Avg. volume (3M)
5.89M

Allogene Therapeutics, Inc. (ALLO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Allogene Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$10.25
+682.44% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ALLO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

John Newman
Canaccord Genuity
BuyMaintains
$14.00
Brian Cheng
JP Morgan
HoldMaintains
-
Sami Corwin
William Blair
BuyMaintains
-
Biren Amin
Piper Sandler
BuyMaintains
$10.00
Tyler Van Buren
TD Cowen
BuyMaintains
-
Unknown Analyst
UBS
BuyReiterates
$8.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Luca Issi
RBC Capital
BuyReiterates
$9.00
Tyler Van Buren
TD Cowen
BuyMaintains
-
Luca Issi
RBC Capital
BuyReiterates
$9.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ALLO?

The analyst consensus rating for ALLO is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for ALLO?

The average 12-month price target for ALLO is $10.25, representing an upside of 682.4% from the Oct 16, 2026 close of $1.31.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.